Study of ASP2998 alone or with other therapies for solid tumors
Treatments studied
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial tests a new drug, ASP2998, given alone or with standard cancer treatments for people with advanced solid tumors, including certain types of lung, bladder, stomach, and breast cancers. The goal is to see if ASP2998 can help when other treatments have stopped working or are not an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that has spread or cannot be removed by surgery.
- Your cancer has progressed after prior treatment, or you are not able to receive standard therapies.
- You have one of these cancer types: lung (non-squamous), bladder, stomach/GEJ, or breast (HER2-negative).
- You are well enough to be up and about (ECOG score 0 or 1) and expected to live at least 3 months.
- You have at least one tumor that can be measured on scans.
- You are not pregnant, breastfeeding, or planning to donate eggs or sperm during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ASP388B, given alone or with standard treatments, for people with certain advanced solid tumors that have stopped responding to therapy. It may help shrink tumors or slow their growth.
This trial tests a new drug called ASP1002, alone or with other treatments, for people with advanced solid tumors that have stopped responding to standard therapies. It aims to see if ASP1002 can shrink tumors or slow their growth.
This trial tests a new investigational drug, BMS-986488, alone or with another drug (adagrasib), for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and works against certain cancers.
This study tests a new drug (ASP5834) for people with advanced solid tumors that have changes in the KRAS gene. The study looks for a safe and effective dose, and may help you if your standard treatments have stopped working.
This trial tests a new drug, ASP3082, for people with advanced non-small cell lung cancer or pancreatic cancer that has a specific gene change called KRAS G12D. The study will collect tumor and blood samples to understand how the cancer responds or becomes resistant to the treatment.
This trial tests a new medicine, PF-08046876, for people with advanced cancers of the bladder, lung, head and neck, esophagus, or pancreas. It aims to see if the drug is safe and works against these cancers.
Hear when a new Locally Advanced or Metastatic Malignant Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.